Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Legend Biotech(LEGN) the Revenue is 387.5 M (+51.93%), Beat estimate;the EBIT is 58 M (+148.5%), Beat estimate;the EPS is 0.18 (+126.5%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.39B51.93%
0.35B37.91%
+0.04B14.02%
EBITExceed expectations
0.06B148.50%
0.02B117.53%
+0.04B30.97%
EPSMiss expectations
0.18126.47%
0.2537137.31%
-0.073710.84%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf